Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Albendazole and praziquantel can cause severe side effects, especially with prolonged use or liver issues.

Drug repurposing offers promising strategies to improve tuberculosis treatment despite challenges.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Certain drugs that block specific enzymes can help treat prostate diseases.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

A man lost all his hair as a rare side effect after hepatitis C treatment.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

SARS-CoV-2 may worsen IPF due to shared genes and pathways, suggesting potential drug targets.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

Calprotectin starves Pseudomonas aeruginosa of essential metals, affecting its growth and resistance.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Tribulus terrestris may protect the liver from drug damage.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

PrrH sRNA controls pyochelin production in *Pseudomonas aeruginosa*.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Inhibiting HSP90 increases cell adaptability and survival under stress.

Plant compounds may boost antiviral treatments.